Picture of Idorsia logo

IDIA — Idorsia News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Brief: Idorsia Full Year EPS -1.45 Chf

March 4 (Reuters) - IDORSIA LTD IDIA.S:

FY EPS CHF -1.45

FY NET INCOME CHF -264 MILLION

FY REVENUE CHF 113 MILLION

FY EBIT CHF -232 MILLION

OUTLOOK 2025 QUVIVIQ NET SALES OF AROUND CHF 110 MILLION

OUTLOOK 2025 SG&A EXPENSES OF AROUND CHF 210 MILLION, RESEARCH AND DEVELOPMENT EXPENSE OF AROUND CHF 100 MILLION, LEADING TO NON-GAAP OPERATING EXPENSES OF AROUND CHF 325 MILLION

OUTLOOK 2025 US GAAP LOSS FOR GLOBAL BUSINESS OF AROUND CHF 155 MILLION

COMMERCIAL PROFITABILITY FORECAST IN 2026

OVERALL PROFITABILITY FORECAST FOR 2027

Source text: ID:nGNE9JydDY

Further company coverage: IDIA.S

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Idorsia

See all news